If you havent already, be sure to check out CardioNerds episode #350 where we discuss the basics and mechanism of action of GLP-1 RAs with Dr
Medicines containing semaglutide: PRAC investigating risk of rare eye condition PRAC will assess risk of non-arteritic anterior ischemic optic neuropathy (NAION) EMAs safety committee, PRAC, has started a review of medicines containing semaglutide following concerns regarding an increased risk of developing NAION, a rare eye condition, as suggested in two recent observational studies, while two other recent observational studies do not suggest an increased risk
Neurological symptoms, such as numbness or tingling in the hands and feet, difficulty walking, and memory problems, are also symptoms
Anaphylaxis is a severe reaction to a trigger, such as an allergy, and is potentially life threatening
However, some peptides are extremely unstable and will lose their potency very quickly after reconstitution
Imagine if the water in our taps were so toxic that pharma companies had to create a drug to make us not thirsty so we wouldn't drink the water that's kind of what's happening with these medications